# Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women

> **NCT03354598** · PHASE3 · COMPLETED · sponsor: **Iterum Therapeutics, International Limited** · enrollment: 1671 (actual)

## Conditions studied

- Uncomplicated Urinary Tract Infections

## Interventions

- **DRUG:** Sulopenem-Etzadroxil/Probenecid
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT03354598
- **Lead sponsor:** Iterum Therapeutics, International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-01-16
- **Final completion:** 2020-01-20
- **Target enrollment:** 1671 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03354598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03354598, "Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03354598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*